Professor Desmond J Sheridan MD PhD FRCP

Publications


Journals

  • Sheridan DJ; Heusch G. (14 Mar 2009). Threats to the future of cardiovascular research. LANCET. 373:875-876. Author weblink.
  • McGoldrick RB; Kingsbury M; Turner MA; Sheridan DJ; Hughes AD. (Dec 2007). Left ventricular hypertrophy induced by aortic banding impairs relaxation of isolated coronary arteries. Clin Sci (Lond). 113:473-478. DOI.
  • Stavrou BM; Tawfik Abdel-Rahman SED; Pintor J; Gualiz J; Miras-Portugal MT; Sheridan DJ; Flores NA. (2001). Cardiac effects of diinosine tetraphosphate, a putative dinucleotide receptor antagonist. Drug Dev Res. 52:500-503.
  • Gray RP; Turner MA; Sheridan DJ; Fry CH. (1 Feb 2007). The role of angiotensin receptor-1 blockade on electromechanical changes induced by left ventricular hypertrophy and its regression. CARDIOVASCULAR RESEARCH. 73:539-548. Author weblink DOI.
  • Sheridan DJ. (20 May 2006). Reversing the decline of academic medicine in Europe. Lancet. 367:1698-1701. DOI.
  • FLORES NA; JUHASZ C; SHERIDAN DJ; WINTERTON SJ. (1 Nov 1989). AN IBM PC AT-BASED SYSTEM FOR THE ANALYSIS OF CARDIAC ACTION-POTENTIALS IN REAL-TIME. JOURNAL OF PHYSIOLOGY-LONDON. 418:P8-P8. Author weblink.
  • MCAINSH AM; OHARE D; SHERIDAN DJ; WINLOVE CP. (1 Jan 1992). CONTINUOUS MEASUREMENT OF OXYGEN-TENSION IN THE ISOLATED GUINEA-PIG HEART USING A PURPOSE DESIGNED OXYGEN-ELECTRODE. JOURNAL OF PHYSIOLOGY-LONDON. 452:P126-P126. Author weblink.
  • DAVIES RH; PARKER KH; SHERIDAN DJ. (1 Aug 1992). THE EFFECT OF THE VALSALVA MANEUVER ON WAVE INTENSITY IN THE HUMAN AORTA - AN ANALYSIS USING THE METHOD OF CHARACTERISTICS. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. 24:S41-S41. Author weblink DOI.
  • McAinsh AM; Turner MA; OHare D; Nithythyananthan R; Johnston DG; OGorman DJ; Sheridan DJ. (1 Dec 1995). Cardiac hypertrophy impairs recovery from ischaemia because there is a reduced reactive hyperaemic response (vol 30, pg 113, 1995). CARDIOVASCULAR RESEARCH. 30:1044-1044. Author weblink DOI.
  • Fluck DS; Etherington PJE; OHare D; Sheridan DJ; Winlove CP. (1 May 1996). Solute exchange in the ischaemic myocardium: The voltammetric hydrogen clearance technique and radioactive microspheres. HEART. 75:47-47. Author weblink.
  • Flores NA; Botchway A; Cohen H; Fry CH; Sheridan DJ. (1 Nov 1996). Electrophysiological changes in isolated guineapig ventricular myocytes following exposure to products of the platelet release reaction. JOURNAL OF PHYSIOLOGY-LONDON. 497P:P55-P55. Author weblink.
  • Siminiak T; Smielecki J; Dye JF; Balinski M; More R; Wysocki H; Sheridan DJ. (1 Feb 1997). Increased release of the soluble endothelial adhesion molecule ICAM-1 but not ELAM-1 during episodes of angina pectoris. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 29:7805-7805. Author weblink.
  • Siminiak T; Smielecki J; Dye JF; Szczepanik A; More R; Wysocki H; Sheridan DJ. (1 Feb 1997). Plasma levels in soluble adhesion molecules VCAM-1 and L-selectin during acute myocardial infarction. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 29:97044-97044. Author weblink.
  • Sheridan DJ. (29 Mar 1997). Resources for cardiogenic shock. LANCET. 349:951-951. Author weblink DOI.
  • Huang WX; Turner MA; Kingsbury MP; Sheridan DJ. (1 Mar 1998). Evidence of an increase in vasodilator efficacy in isolated thoracic aorta from guinea-pigs after chronic ascending aortic banding. BRITISH JOURNAL OF PHARMACOLOGY. 123:U178-U178. Author weblink.
  • Stavrou BM; Sheridan DJ; Flores NA. (1 Jun 1998). Cardiac electrophysiological and haemodynamic effects of diadenosine polyphosphates in the isolated perfused guinea-pig heart. JOURNAL OF PHYSIOLOGY-LONDON. 509P:150P-151P. Author weblink.
  • Flores NA; Botchway ANS; Stavrou BM; Sheridan DJ. (1 Mar 1999). Cardiac electrophysiological effects of platelet-derived substances. EXPERIMENTAL PHYSIOLOGY. 84:253-273. Author weblink DOI.
  • Kingsbury MP; Teevan CP; Turner MA; Sheridan DJ. (1 Jun 1999). Endothelium-dependent and -independent coronary vasodilator responses are reduced in left ventricular hyptertrophy. BRITISH JOURNAL OF PHARMACOLOGY. 127:U58-U58. Author weblink.
  • Huang WX; Kingsbury MP; Hunter RJ; Turner MA; Sheridan DJ. (1 Jun 1999). Evidence of increased endothelium-mediated vasodilatation following chronic aortic constriction. BRITISH JOURNAL OF PHARMACOLOGY. 127:U57-U57. Author weblink.
  • Stavrou BM; Blackburn GM; Sheridan DJ; Flores NA. (2 Nov 1999). Diadenosine polyphosphates: Platelet-derived compounds with patent purinergic actions on cardiac hemodynamics and electrophysiology. CIRCULATION. 100:61-61. Author weblink.
  • Flores NA; Botchway ANS; Turner MA; Cohen H; Sheridan DJ. (1 Feb 2000). Products of the platelet release reaction accentuate the ischaemia-induced reduction in action potential duration (APD(95)) in the isolated perfused guinea-pig heart. JOURNAL OF PHYSIOLOGY-LONDON. 523:111P-112P. Author weblink.
  • Botchway ANS; Turner MA; Fry CH; Sheridan DJ; Flores NA. (1 Feb 2000). Electrophysiological changes during myocardial ischaemia and reperfusion associated with regression of left ventricular. JOURNAL OF PHYSIOLOGY-LONDON. 523:105P-106P. Author weblink.
  • Botchway ANS; Turner MA; Sheridan DJ; Flores NA; Fry CH. (1 Feb 2000). Myocardial conduction and action potential duration during regression of left ventricular hypertrophy in the guinea-pig. JOURNAL OF PHYSIOLOGY-LONDON. 523:104P-105P. Author weblink.
  • Botchway ANS; Flores NA; Sheridan DJ; Cohen H. (1 Feb 2000). Storage pool defect in pooled huffy coat platelet concentrates within the shelf-life period. CLINICAL AND LABORATORY HAEMATOLOGY. 22:21-27. Author weblink DOI.
  • Huang W; Kingsbury MP; Turner MA; Flores NA; Sheridan DJ. (1 Jun 2000). Lung remodelling inhibits the development of pulmonary oedema following adaptation to chronic heart failure in the guinea-pig. JOURNAL OF PHYSIOLOGY-LONDON. 525:35P-35P. Author weblink.
  • Turner MA; Botchway ANS; Flores NA; Sheridan DJ. (1 Jun 2000). Induction and regression of left ventricular hypertrophy in the guinea-pig. JOURNAL OF PHYSIOLOGY-LONDON. 525:6P-6P. Author weblink.
  • Gosse P; Sheridan DJ; Zannad F; Dubourg O; Gueret P; Karpov Y; de Leeuw PW; Palma-Gamiz JL; et alPessina A; Motz W; Degaute JP; Chastang C. (1 Oct 2000). Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study. JOURNAL OF HYPERTENSION. 18:1465-1475. Author weblink DOI.
  • Stavrou BM; Sheridan DJ; Flores NA. (1 Aug 2000). Differential involvement of endothelium-derived nitric oxide and prostacyclin in the cardiac vasomotor and electrophysiological effects of diadenosine tetraphosphate and pentaphosphate in the guinea-pig. JOURNAL OF PHYSIOLOGY-LONDON. 526:99P-99P. Author weblink.
  • Botchway ANS; Turner MA; Fry CH; Sheridan DJ; Flores NA. (1 Aug 2000). Electrophysiological changes during myocardial ischaemia and reperfusion associated with regression of left ventricular hypertrophy for 100 days in the guinea-pig. JOURNAL OF PHYSIOLOGY-LONDON. 526:96P-96P. Author weblink.
  • Botchway ANS; Turner MA; Sheridan DJ; Flores NA; Fry CH. (1 Aug 2000). Conduction and contractility changes during prolonged regression of left ventricular hypertrophy in the guinea-pig. JOURNAL OF PHYSIOLOGY-LONDON. 526:82P-82P. Author weblink.
  • Kingsbury MP; Huang W; Turner MA; Flores NA; Sheridan DJ. (1 May 2001). Resistance to pulmonary oedema in anaesthetised guinea-pigs with chronic heart failure. JOURNAL OF PHYSIOLOGY-LONDON. 533:90P-90P. Author weblink.
  • McGoldrick RB; Kingsbury MP; Turner MA; Sheridan DJ; Hughes AD. (1 Oct 2001). Effect of heart failure induced by aortic banding in guinea pigs on vasodilation of coronary and mesenteric small arteries in vitro. HYPERTENSION. 38:970-970. Author weblink.
  • Sheridan DJ. (17 Apr 2004). Complexities of equitable drug availability. LANCET. 363:1327-1327. Author weblink DOI.
  • Sheridan DJ. (3 Dec 2005). Reforming research in the NHS. BRITISH MEDICAL JOURNAL. 331:1339-1340. Author weblink DOI.
  • WALKER MJA; CURTIS MJ; HEARSE DJ; CAMPBELL RWF; JANSE MJ; YELLON DM; COBBE SM; COKER SJ; et alHARNESS JB; HARRON DWG; HIGGINS AJ; JULIAN DG; LAB MJ; MANNING AS; NORTHOVER BJ; PARRATT J; RIEMERSMA RA; RIVA E; RUSSELL DC; SHERIDAN DJ; WINSLOW E; WOODWARD B. (1 Jul 1988). THE LAMBETH CONVENTIONS - GUIDELINES FOR THE STUDY OF ARRHYTHMIAS IN ISCHEMIA, INFARCTION, AND REPERFUSION. CARDIOVASCULAR RESEARCH. 22:447-455. Author weblink DOI.
  • RADVAN J; CAMICI PG; MARWICK T; BOYD H; SHERIDAN DJ. (1 Oct 1993). PHYSIOLOGICAL HYPERTROPHY DOES NOT AFFECT CORONARY FLOW RESERVE IN MAN. CIRCULATION. 88:214-214. Author weblink.
  • CHOUDHURY L; RADVAN J; SHERIDAN DJ; OAKLEY CM; CAMICI PG. (1 Feb 1994). CORONARY FLOW RESERVE MEASUREMENT ALLOWS DIFFERENTIATION OF HYPERTROPHIC CARDIOMYOPATHY FROM THE ATHLETES HEART. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. A160-A160. Author weblink.
  • Rajappan K; Rimoldi OE; Ariff B; Pennell DJ; Sheridan DJ; Camici PG. (31 Oct 2000). The impairment of coronary vasodilator reserve is related to the severity of aortic stenosis. CIRCULATION. 102:785-785. Author weblink.
  • Rajappan K; Mayet J; Rimoldi O; Camici PG; Sheridan DJ. (1 Feb 2001). ECG changes and microcirculatory dysfunction in aortic valve stenosis. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 37:482A-482A. Author weblink.
  • Rajappan K; Rimoldi O; Schafers KP; Pennell DJ; Sheridan DJ; Camici PG. (1 Feb 2001). Evidence of stress-induced subendocardial hypoperfusion in patients with aortic stenosis demonstrated by positron emission tomography. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 37:419A-420A. Author weblink.
  • Rajappan K; Rimoldi O; Sheridan DJ; Camici PG; Pennell DJ. (1 Sep 2001). A study of transmural blood flow in patients with aortic stenosis using positron emission tomography. EUROPEAN HEART JOURNAL. 22:574-+. Author weblink.
  • Rajappan K; Rimoldi O; Ariff B; Pennell DJ; Sheridan DJ; Camici PG. (1 Sep 2001). Coronary microcirculatory dysfunction is related to the severity of aortic stenosis. EUROPEAN HEART JOURNAL. 22:309-309. Author weblink.
  • Rajappan K; Rimoldi O; Pennell DJ; Camici PG; Sheridan DJ; Moat N; DeSouza AC; Pepper J. (1 Sep 2001). Regression of LVH and changes in coronary microcirculation after valve replacement in aortic stenosis. EUROPEAN HEART JOURNAL. 22:95-95. Author weblink.
  • Rajappan V; Rimoldi O; Ariff B; Pennell DJ; Sheridan DJ; Camici PG. (23 Oct 2001). Impairment of coronary microcirculation in aortic stenosis is related to aortic valve area. CIRCULATION. 104:360-360. Author weblink.
  • Rajappan K; Rimoldi O; Bellenger NG; Pennell DJ; Camici PG; Sheridan DJ. (23 Oct 2001). Functional changes in coronary microcirculation with regression of LVH. CIRCULATION. 104:113-113. Author weblink.
  • Sheridan JV; Thomas P; Sheridan DJ. (1987). Felodipine in ischaemic heart disease. Drugs. 34 Suppl 3:71-78.
  • Dixon MS; Thomas P; Sheridan DJ. (Apr 1988). Syncope as the presentation of unstable angina. Int J Cardiol. 19:125-129.
  • Thomas P; Sheridan DJ. (Sep 1988). Coronary thrombolysis. Q J Med. 68:657-663.
  • Flores NA; Sheridan DJ. (Mar 1989). Electrophysiological and antiarrhythmic effects of UK 52,046-27 during ischaemia and reperfusion in the guinea-pig heart. Br J Pharmacol. 96:670-674.
  • Thomas P; Dixon MS; Culling W; Sheridan DJ. (Sep 1989). Changes in the haemodynamic responses to exercise, posture and nitrates after treatment of congestive heart failure with an arteriolar vasodilator. Clin Sci (Lond). 77:229-236.
  • Kennerdy A; Thomas P; Sheridan DJ. (Oct 1989). Generalized seizures as the presentation of flecainide toxicity. Eur Heart J. 10:950-954.
  • Thomas P; Sheridan DJ. (1990). Vascular selectivity of felodipine: clinical experience. J Cardiovasc Pharmacol. 15 Suppl 4:S17-S20.
  • Dixon MS; Thomas P; Sheridan DJ. (1990). A randomized double-blind study of bisoprolol versus atenolol in mild to moderate essential hypertension. Eur J Clin Pharmacol. 38:21-24.
  • Thomas P; Dixon MS; Winterton SJ; Sheridan DJ. (Mar 1990). Acute haemodynamic effects of cromakalim in patients with angina pectoris. Br J Clin Pharmacol. 29:325-331.
  • Flores NA; Sheridan DJ. (Nov 1990). Electrophysiological and arrhythmogenic effects of platelet activating factor during normal perfusion, myocardial ischaemia and reperfusion in the guinea-pig. Br J Pharmacol. 101:734-738.
  • Flores NA; Seghatchian MJ; Sheridan DJ. (Apr 1991). Platelet-mediated alterations in cardiac cellular electrophysiology. Blood Coagul Fibrinolysis. 2:367-371.
  • Chakrabarty S; Thomas P; Sheridan DJ. (Apr 1991). Arrhythmias, haemodynamic changes and extent of myocardial damage during coronary ligation in rabbits anaesthetized with halothane, alpha chloralose or pentobarbitone. Int J Cardiol. 31:9-14.
  • Chakrabarty S; Thomas P; Sheridan DJ. (May 1991). Contribution of platelets and platelet-activating factor (PAF) to the arrhythmogenic, haemodynamic and necrotic effects of acute myocardial ischaemia. Eur Heart J. 12:583-589.
  • Flores NA; Sheridan DJ. (Aug 1991). Electrophysiological effects of alpha-adrenoceptor stimulation in perfused and superfused myocardium. J Mol Cell Cardiol. 23:973-985.
  • O'Gorman DJ; Sheridan DJ. (Dec 1991). Abnormalities of the coronary circulation associated with left ventricular hypertrophy. Clin Sci (Lond). 81:703-713.
  • Turner MA; Thomas P; Sheridan DJ. (Jan 1992). An improved method for direct laryngeal intubation in the guineapig. Lab Anim. 26:25-28.
  • Jones CJ; Parker KH; Hughes R; Sheridan DJ. (Feb 1992). Nonlinearity of human arterial pulse wave transmission. J Biomech Eng. 114:10-14.
  • O'Gorman DJ; Thomas P; Turner MA; Sheridan DJ. (May 1992). Investigation of impaired coronary vasodilator reserve in the guinea pig heart with pressure induced hypertrophy. Eur Heart J. 13:697-703.
  • Chakrabarty S; Fluck DS; Flores NA; Sheridan DJ. (Nov 1992). Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits. Br J Pharmacol. 107:705-709.
  • Burton T; Chakrabarty S; Fluck DS; Flores NA; Sheridan DJ. (Dec 1992). Effects of cicletanine on haemodynamics, arrhythmias and extent of necrosis during coronary ligation in rabbits. Br J Pharmacol. 107:1135-1139.
  • Sheridan DJ; McAinsh A; O'Gorman DJ. (1993). The coronary circulation in cardiac hypertrophy. J Cardiovasc Pharmacol. 22 Suppl 6:S18-S28.
  • Davies RH; Sheridan DJ. (Jun 1993). The treatment of heart failure--what next?. Br J Clin Pharmacol. 35:557-563.
  • Winterton SJ; Turner MA; O'Gorman DJ; Flores NA; Sheridan DJ. (Jan 1994). Hypertrophy causes delayed conduction in human and guinea pig myocardium: accentuation during ischaemic perfusion. Cardiovasc Res. 28:47-54.
  • Flores NA; Sheridan DJ. (Mar 1994). The pathophysiological role of platelets during myocardial ischaemia. Cardiovasc Res. 28:295-302.
  • Chakrabarty S; Fluck DS; Flores NA; Sheridan DJ. (May 1994). Effects of streptokinase on infarct size in rabbits in the presence and absence of coronary artery recanalization. Eur Heart J. 15:699-704.
  • Geroulakos G; O'Gorman DJ; Kalodiki E; Sheridan DJ; Nicolaides AN. (Jun 1994). The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur Heart J. 15:781-785.
  • Egdell RM; Siminiak T; Sheridan DJ. (Nov 1994). Modulation of neutrophil activity by nitric oxide during acute myocardial ischaemia and reperfusion. Basic Res Cardiol. 89:499-509.
  • Flores NA; Goulielmos NV; Seghatchian MJ; Sheridan DJ. (Nov 1994). Myocardial ischaemia induces platelet activation with adverse electrophysiological and arrhythmogenic effects. Cardiovasc Res. 28:1662-1671.
  • Siminiak T; Flores NA; Sheridan DJ. (Feb 1995). Neutrophil interactions with endothelium and platelets: possible role in the development of cardiovascular injury. Eur Heart J. 16:160-170.
  • McAinsh AM; Turner MA; O'Hare D; Nithythyananthan R; Johnston DG; O'Gorman DJ; Sheridan DJ. (Jul 1995). Cardiac hypertrophy impairs recovery from ischaemia because there is a reduced reactive hyperaemic response. Cardiovasc Res. 30:113-121.
  • Siminiak T; Egdell RM; O'Gorman DJ; Dye JF; Sheridan DJ. (Aug 1995). Plasma-mediated neutrophil activation during acute myocardial infarction: role of platelet-activating factor. Clin Sci (Lond). 89:171-176.
  • Goulielmos NV; Enayat ZE; Sheridan DJ; Cohen H; Flores NA. (Nov 1995). Nitric oxide and prostacyclin modulate the alterations in cardiac action potential duration mediated by platelets during ischaemia. Cardiovasc Res. 30:788-798.
  • Siminiak T; O'Gorman DJ; Shahi M; Hackett D; Sheridan DJ. (Dec 1995). Plasma mediated neutrophil stimulation during coronary angioplasty: autocrine effect of platelet activating factor. Br Heart J. 74:625-630.
  • Carey PA; Sheridan DJ; de Cordoue A; Guez D. (22 Feb 1996). Effect of indapamide on left ventricular hypertrophy in hypertension: a meta-analysis. Am J Cardiol. 77:17b-19b.
  • Fluck DS; Etherington PJ; O'Hare D; Winlove CP; Sheridan DJ. (Nov 1996). Myocardial tissue perfusion determined by particulate and diffusible tracers during ischaemia: what is measured?. Cardiovasc Res. 32:869-878.
  • Siminiak T; Dye JF; Egdell RM; More R; Wysocki H; Sheridan DJ. (19 Sep 1997). The release of soluble adhesion molecules ICAM-1 and E-selectin after acute myocardial infarction and following coronary angioplasty. Int J Cardiol. 61:113-118.
  • Radvan J; Choudhury L; Sheridan DJ; Camici PG. (15 Dec 1997). Comparison of coronary vasodilator reserve in elite rowing athletes versus hypertrophic cardiomyopathy. Am J Cardiol. 80:1621-1623.
  • Cooklin M; Wallis WR; Sheridan DJ; Fry CH. (Nov 1998). Conduction velocity and gap junction resistance in hypertrophied, hypoxic guinea-pig left ventricular myocardium. Exp Physiol. 83:763-770.
  • Fluck DS; Etherington PJ; Sheridan DJ; Winlove CP. (Oct 1998). Solute exchange in the rabbit myocardium: ischaemia, reflow, and myocardial necrosis. Basic Res Cardiol. 93:354-360.
  • Kingsbury MP; Huang W; Giuliatti S; Turner M; Hunter R; Parker K; Sheridan DJ. (Mar 1999). Investigation of distal aortic compliance and vasodilator responsiveness in heart failure due to proximal aortic stenosis in the guinea pig. Clin Sci (Lond). 96:241-251.
  • Sheridan DJ; Kingsbury MP; Flores NA. (Feb 1999). Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?. Br J Clin Pharmacol. 47:125-130.
  • Flores NA; Botchway AN; Stavrou BM; Sheridan DJ. (Mar 1999). Cardiac electrophysiological effects of platelet-derived substances. Exp Physiol. 84:253-274.
  • Flores NA; Stavrou BM; Sheridan DJ. (Apr 1999). The effects of diadenosine polyphosphates on the cardiovascular system. Cardiovasc Res. 42:15-26.
  • Kingsbury MP; Turner MA; Flores NA; Bovill E; Sheridan DJ. (Mar 2000). Endogenous and exogenous coronary vasodilatation are attenuated in cardiac hypertrophy: a morphological defect?. J Mol Cell Cardiol. 32:527-538. DOI.
  • Botchway AN; Flores NA; Sheridan DJ; Cohen H. (Feb 2000). Storage pool defect in pooled buffy coat platelet concentrates within the shelf-life period. Clin Lab Haematol. 22:21-28.
  • Bakhai A; Sheridan DJ; Coutelle CC. (3 Apr 2002). "Bronchial artery delivery of viral vectors for gene delivery in cystic fibrosis; superior to airway delivery?". BMC Pulm Med. 2:2.
  • Berger E; Patel K; Anwar S; Davies W; Sheridan DJ. (Jul 2005). Investigation of the effects of physiological and vasodilation-induced autonomic activation on the QTc Interval in healthy male subjects. Br J Clin Pharmacol. 60:17-23. DOI.
  • Botchway AN; Turner MA; Sheridan DJ; Flores NA; Fry CH. (1 Dec 2003). Electrophysiological effects accompanying regression of left ventricular hypertrophy. Cardiovasc Res. 60:510-517.
  • Kingsbury MP; Huang W; Donnelly JL; Jackson E; Needham E; Turner MA; Sheridan DJ. (Sep 2003). Structural remodelling of lungs in chronic heart failure. Basic Res Cardiol. 98:295-303. DOI.
  • Rajappan K; Bellenger NG; Melina G; Di Terlizzi M; Yacoub MH; Sheridan DJ; Pennell DJ. (Jul 2003). Assessment of left ventricular mass regression after aortic valve replacement--cardiovascular magnetic resonance versus M-mode echocardiography. Eur J Cardiothorac Surg. 24:59-65.
  • Rajappan K; Rimoldi OE; Camici PG; Bellenger NG; Pennell DJ; Sheridan DJ. (1 Jul 2003). Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis. Circulation. 107:3170-3175. DOI.
  • Rajappan K; O'Connell C; Sheridan DJ. (Feb 2003). Changes in QT interval with exercise in elite male rowers and controls. Int J Cardiol. 87:217-222.
  • Kingsbury M; Mahnke A; Turner M; Sheridan D. (Jul 2002). Recovery of coronary function and morphology during regression of left ventricular hypertrophy. Cardiovasc Res. 55:83-96.
  • El-Gendi H; Violaris AG; Foale R; Sharma HS; Sheridan DJ. (Feb 2002). Endogenous, local, vascular endothelial growth factor production in patients with chronic total coronary artery occlusions: further evidence for its role in angiogenesis. Heart. 87:158-159.
  • Rajappan K; Rimoldi OE; Dutka DP; Ariff B; Pennell DJ; Sheridan DJ; Camici PG. (29 Jan 2002). Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation. 105:470-476.
  • Stavrou BM; Sheridan DJ; Flores NA. (Aug 2001). Contribution of nitric oxide and prostanoids to the cardiac electrophysiological and coronary vasomotor effects of diadenosine polyphosphates. J Pharmacol Exp Ther. 298:531-538.
  • Carey PA; Turner M; Fry CH; Sheridan DJ. (Jul 2001). Reduced anisotropy of action potential conduction in left ventricular hypertrophy. J Cardiovasc Electrophysiol. 12:830-835.
  • Stavrou BM; Lawrence C; Blackburn GM; Cohen T; Sheridan DJ; Flores NA. (May 2001). Coronary vasomotor and cardiac electrophysiologic effects of diadenosine polyphosphates and nonhydrolyzable analogs in the guinea pig. J Cardiovasc Pharmacol. 37:571-584.
  • Wallis W; Cooklin M; Sheridan DJ; Fry CH. (Apr 2001). The action of isoprenaline on the electrophysiological properties of hypertrophied left ventricular myocytes. Arch Physiol Biochem. 109:117-126. DOI.
  • Kingsbury MP; Robinson H; Flores NA; Sheridan DJ. (Mar 2001). Investigation of mechanisms that mediate reactive hyperaemia in guinea-pig hearts: role of K(ATP) channels, adenosine, nitric oxide and prostaglandins. Br J Pharmacol. 132:1209-1216. DOI.
  • Morris-Jones R; Staughton RC; Walker M; Sheridan DJ; Rajappan K; Leonard J; Hardman C. (Mar 2001). Lichen myxoedematosus with associated cardiac abnormalities. Br J Dermatol. 144:594-596.
  • Huang W; Kingsbury MP; Turner MA; Donnelly JL; Flores NA; Sheridan DJ. (Jan 2001). Capillary filtration is reduced in lungs adapted to chronic heart failure: morphological and haemodynamic correlates. Cardiovasc Res. 49:207-217.
  • Flores NA; Botchway AN; Turner MA; Cohen H; Sheridan DJ. (Nov 2000). Products of the platelet release reaction influence cardiac electrophysiology independently of platelet-platelet interactions. Platelets. 11:415-417.
  • Sheridan DJ. (Oct 2000). Drug-induced proarrhythmic effects: assessment of changes in QT interval. Br J Clin Pharmacol. 50:297-302.
  • Sheridan DJ. (Jul 2000). Regression of left ventricular hypertrophy: do antihypertensive classes differ?. J Hypertens Suppl. 18:S21-S27.
  • Sheridan DJ. (Dec 1999). Left ventricular hypertrophy regression: the LIVE trial. Cardiologia. 44 Suppl 1:541-543.
  • Thomas P; O'Gorman DJ; Sheridan DJ. (Dec 1993). Acute and chronic effects of flosequinan on resting and exercise haemodynamics in congestive heart failure. Br J Clin Pharmacol. 36:539-546.

Books

  • Sheridan DJ. Sheridan DJ (ed). Left Ventricular Hypertrophy. Churchill Communications (1998).
  • Atun R; Sheridan DJ; Attridge J; Sikora K; Harvey I; Wild J; Gurol-Urganci I; Kleyn D; et alKitney R. Atun RA (ed); Sheridan DJ (ed). Innovation in the Biopharmaceutical Industry. 1-140. World Scientific Publishing Company, Singapore (2007).

Conferences

  • Sheridan DJ. The pathophysiology of left ventricular hypertrophy and its importance as a coronary risk faster. Symposium on Hypertension - Other Risk Factors Considered, 1 May 1996. 6-9. ROYAL SOC MEDICINE PRESS (1 Jan 1996). Author weblink.
  • Rajappan K; Rimoldi O; Pennell DJ; Camici PG; Sheridan DJ. Coronary microcirculatory dysfunction in aortic stenosis. 28th Annual Meeting on Computers in Cardiology, 23 Sep 2001 - 26 Sep 2001. 28:289-292. IEEE (1 Jan 2001). Author weblink.
  • Rajappan K; Rimoldi O; Camici PG; Pennell DJ; Sheridan DJ. Factors influencing coronary microcirculatory function in patients with aortic stenosis after aortic valve replacement. American-Heart-Association Abstracts From Scientific Sessions. 106:640-641. (5 Nov 2002).
  • Mahnke A; Rimoldi O; Camici PG; Maceira A; Prasad S; Pennell D; Sheridan DJ. Early left ventricular mass regression and changes in coronary microcirculatory function in patients with aortic stenosis after valve replacement. 76th Annual Scientific Session of the American-Heart-Association. 108:431-431. (28 Oct 2003).
  • Scoote M; Harding SE; MacLeod KT; Kingsbury MP; Sheridan DJ; Williams AJ. Functional characteristics of the cardiac ryanodine receptor in an experimental model of heart failure. 24th Annual Scientific Sessions of the European-Section of the International-Society-for-Heart-Research. 36:757-758. (May 2004).
  • Scoote M; Harding SE; MacLeod KT; Kingsbury MP; Sheridan DJ; Williams AJ. Altered cardiac ryanodine receptor: dihydropyridine receptor stoichiometry in an experimental model of heart failure. 24th Annual Scientific Sessions of the European-Section of the International-Society-for-Heart-Research. 36:732-732. (May 2004).
  • Scoote M; MacLeod KT; Harding SE; Kingsbury MP; Turner MA; Sheridan DJ; Williams AJ. Sarcolemmal L-type calcium channel : Intracellular calcium release channel (ryanodine receptor) stoichiometry is reduced in pressure overload heart failure but not in chronic catecholaminergic exposure. 49th Annual Meeting of the Biopysical-Society. 88:487A-488A. (Jan 2005).
  • Gray RP; Sheridan DJ; Fry CH. Intracellular Ca(2+) regulation in isolated myocytes from guinea-pigs with left ventricular hypertrophy induced by constriction of the thoracic aorta. Meeting of the Physiological-Society, 10 Sep 2002 - 12 Sep 2002. 544:56P-56P. WILEY-BLACKWELL (1 Nov 2002). Author weblink.
  • Fry CH; Sheridan DJ; Gray RP. Intracellular pH, H(+) buffering capacity and H(+) extrusion in isolated myocytes from guinea-pigs with left ventricular hypertrophy induced by thoracic-aortic constriction. Meeting of the Physiological-Society, 10 Sep 2002 - 12 Sep 2002. 544:52P-52P. WILEY-BLACKWELL (1 Nov 2002). Author weblink.
  • Fry CH; Gray RP; Sheridan DJ. Discontinuous action potential propagation in hypertrophied left ventricular guinea-pig myocardium. Scientific Meeting of the Physiological-Society, 5 Sep 2001 - 7 Sep 2001. 536:79P-80P. WILEY-BLACKWELL (1 Nov 2001). Author weblink.
  • Christofi FM; Kingsbury MP; Fuller S; Sheridan DJ. Remodelling of the pulmonary vasculature during the evolution of chronic heart failure is associated with early upregulation and late downregulation of the angiotensin II type 1 receptor. 7th Annual Meeting of the European-Council-for-Blood-Pressure-and-Cardiovascular-Research, 11 Oct 2002 - 13 Oct 2002. 40:577-577. LIPPINCOTT WILLIAMS & WILKINS (1 Oct 2002). Author weblink.
  • Hussain W; Patel PM; Carey P; Severs NJ; Sheridan DJ; Fry CH; Peters NS. Changes in anisotropy associated with cellular architecture, and connexin43 expression in a guinea-pig model of left ventricular hypertrophy. 24th Annual Scientific Meeting of the European-Society-of-Cardiology, 31 Aug 2002 - 4 Sep 2002. 23:671-671. OXFORD UNIV PRESS (1 Aug 2002). Author weblink.
  • Roberts CE; Sheridan DJ; Blomley MJ; Nihayannopoulos P; Haskard DO. Characterisation of lung inflammation in a murine myocardial infarction model of heart failure. Annual Conference of the British-Cardiac-Society, 24 May 2004 - 27 May 2004. 90:A49-A49. B M J PUBLISHING GROUP (1 May 2004). Author weblink.
  • El Gendi H; Ismail TF; Violaris AG; Gomma AA; Sheridan DJ. Monocyte L-selectin downregulation triggered by platelet-monocyte adhesion (PMA): A novel target to improve outcome following coronary intervention?. 16th Annual Transcatheter Cardiovascular Therapeutics Symposium, 27 Sep 2004 - 1 Oct 2004. 94:227E-227E. EXCERPTA MEDICA INC (30 Sep 2004). Author weblink.
  • Sheridan DJ. Regression of left ventricular hypertrophy: what are ideal trial design features?. 20th Congress of the European-Society-for-Cardiology, 22 Aug 1998 - 26 Aug 1998. 1:P31-P34. W B SAUNDERS CO LTD (1 Sep 1999).
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook